Skip to content 
Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Its products include EVO756 for the treatment of CSU and AD; and EVO301 for the treatment of AD and UC. The company was incorporated in 2020 and is based in Palo Alto, California. more
| Time Frame | EVMN | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | 3.05% | 1.07% | 0.74% |
| 1-Month Return | 56.14% | 1.46% | 1.28% |
| 3-Month Return | 48.94% | 3.51% | 3.6% |
| 6-Month Return | 42.02% | 15.29% | 7.31% |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| EVMN | |
|---|---|
| ROA (LTM) | 0.00% |
| ROE (LTM) | 0.00% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| EVMN | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 0.00 |
| P/B | 0.00 |
| EV/R | 0.00 |
| EV/Ebitda | NM |
Evommune, Inc. (EVMN) share price today is $28.73
Yes, Indians can buy shares of Evommune, Inc. (EVMN) on Vested. To buy
Yes, you can purchase fractional shares of Evommune, Inc. (EVMN) via the Vested app. You can start investing in Evommune, Inc. (EVMN) with a minimum investment of $1.
You can invest in shares of Evommune, Inc. (EVMN) via Vested in three simple steps:
The 52-week high price of Evommune, Inc. (EVMN) is $33.2. The 52-week low price of Evommune, Inc. (EVMN) is $13.88.
The price-to-earnings (P/E) ratio of Evommune, Inc. (EVMN) is
The price-to-book (P/B) ratio of Evommune, Inc. (EVMN) is 0.00
The dividend yield of Evommune, Inc. (EVMN) is 0.00%
The market capitalization of Evommune, Inc. (EVMN) is $980.40M
The stock symbol (or ticker) of Evommune, Inc. is EVMN
Consider the share price of Evommune, Inc. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Evommune, Inc. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Evommune, Inc. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Evommune, Inc. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Evommune, Inc. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Evommune, Inc. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
